AIDOT (CEO Jung Jae-hoon) announced that it will participate in RSNA 2023 (the Radiological Society of North America 2023), being held in Chicago, USA from November 26 to November 29, 2023, and will showcase AIDOT’s various AI solutions.

RSNA is North America’s largest radiology conference, where cutting-edge medical technologies and innovative research results are shared. It is a long-established conference in which more than 600 companies participate and more than 400 seminars and educational programs are conducted.

At this conference, AIDOT said it plans to present various diagnostic AI solutions it has developed in-house.

Among them, it announced a full-scale entry into the U.S. market for GIGA dot AI, a real-time AI solution for gastroscopy diagnosis that recently obtained MFDS Class 3 approval, and for COLON dot AI, an AI solution for colonoscopy diagnosis. It will also exhibit six solutions in total, including Cerviray AI, which already has partners worldwide, and a U.S.-bound version of Cerviray that has secured FDA 510(k).

In particular, the company stated that the U.S.-bound Cerviray is already eligible for insurance claims through the application of a U.S. medical billing code, CPT.

CEO Jung Jae-hoon of AIDOT said, “Through AI, AIDOT will enable many people to enjoy medical benefits regardless of medical barriers, and will continue to develop products and solutions to promote the health of humankind.”

Korea Economic TV / 2023.11.27 / Deputy Chief Editor Yang Jae-joon